Orbimed Advisors LLC Phasebio Pharmaceuticals Inc C Call Options Transaction History
Orbimed Advisors LLC
- $4.24 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|